Cite
APA Citation
Indini, A., & Grossi, F. (2021). adjuvant pembrolizumab for melanoma: update from the EORTC 1325-MG/KEYNOTE-054 trial. Lancet oncology, 22(5), 573–575. http://access.bl.uk/ark:/81055/vdc_100129544758.0x000013
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Indini, A., & Grossi, F. (2021). adjuvant pembrolizumab for melanoma: update from the EORTC 1325-MG/KEYNOTE-054 trial. Lancet oncology, 22(5), 573–575. http://access.bl.uk/ark:/81055/vdc_100129544758.0x000013